BEONE MEDICINES LTD. (BEIGF) Operating income 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual operating income history from SEC filings — each fiscal year as reported.
$447.1MFY2025 · since FY2016: -$117.1M → $447.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $447.1M | +178.7% |
| FY2024 | -$568.2M | +53.0% |
| FY2023 | -$1.2B | +32.5% |
| FY2022 | -$1.8B | -24.4% |
| FY2021 | -$1.4B | +13.2% |
| FY2020 | -$1.7B | -72.7% |
| FY2019 | -$959.9M | -36.0% |
| FY2018 | -$705.8M | -616.8% |
| FY2017 | -$98.5M | +15.9% |
| FY2016 | -$117.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →